PMC:7696151 / 84989-85241 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"2534","span":{"begin":192,"end":200},"obj":"Species"},{"id":"2546","span":{"begin":87,"end":90},"obj":"Chemical"},{"id":"2567","span":{"begin":212,"end":218},"obj":"Disease"},{"id":"2568","span":{"begin":233,"end":241},"obj":"Disease"}],"attributes":[{"id":"A2534","pred":"tao:has_database_id","subj":"2534","obj":"Tax:9606"},{"id":"A2546","pred":"tao:has_database_id","subj":"2546","obj":"MESH:D006886"},{"id":"A2567","pred":"tao:has_database_id","subj":"2567","obj":"MESH:D009369"},{"id":"A2568","pred":"tao:has_database_id","subj":"2568","obj":"MESH:D008545"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"However, different from Rosenfeld’s studies, no maximum tolerated dose was reached for HCQ in combination with chemotherapic temsirolimus, allowing us to perform a dose-escalation study on 27 patients with solid tumors and 12 with a melanoma diagnosis."}

    LitCovid-PD-HP

    {"project":"LitCovid-PD-HP","denotations":[{"id":"T210","span":{"begin":233,"end":241},"obj":"Phenotype"}],"attributes":[{"id":"A210","pred":"hp_id","subj":"T210","obj":"http://purl.obolibrary.org/obo/HP_0002861"}],"text":"However, different from Rosenfeld’s studies, no maximum tolerated dose was reached for HCQ in combination with chemotherapic temsirolimus, allowing us to perform a dose-escalation study on 27 patients with solid tumors and 12 with a melanoma diagnosis."}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T541","span":{"begin":0,"end":252},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"However, different from Rosenfeld’s studies, no maximum tolerated dose was reached for HCQ in combination with chemotherapic temsirolimus, allowing us to perform a dose-escalation study on 27 patients with solid tumors and 12 with a melanoma diagnosis."}